• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫球蛋白样转录物(ILT)2 和 ILT3 在人胃癌中的表达及其临床意义。

Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance.

机构信息

Department of Clinical Laboratory Medicine, Qilu Hospital of Shandong University, Jinan 250012, PR China.

出版信息

Mol Med Rep. 2012 Apr;5(4):910-6. doi: 10.3892/mmr.2012.744. Epub 2012 Jan 9.

DOI:10.3892/mmr.2012.744
PMID:22246571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3493079/
Abstract

Immune inhibitory receptors play an important role in organ transplantation, autoimmune diseases and cancers. Immunoglobulin-like transcript (ILT)2 and ILT3 belong to the inhibitory receptors of the ILT family, which have been reported to regulate a broad range of cellular functions involved in the immune response. They contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs), which are related to immune regulation. Although ILT receptors have been studied in dendritic cells (DCs), T cells, NK cells and other cell types, the expression and clinical significance of ILT2 and ILT3 in gastric cancer have yet to be elucidated. Here, the expression of ILT2 and ILT3 in gastric cancer cell lines and pathologic tissues, as well as their effects on the cytotoxicity of NK92MI against the gastric cancer cell lines MKNI with ILT2lowILT3low and HGC-27 with ILT2highILT3high were detected. The results suggest that ILT2 and ILT3 are expressed with diverse degrees in gastric cancer cells and tissues, and the expression of ILT2 is related with differentiation and size of tumors. Furthermore, the cytotoxic activity of NK92MI against the MKNI cell line was stronger than that against HGC-27. This study indicates that ILT2 and ILT3 play a key role in gastric cancer immune escape, and ILT2 may be a new target in the clinical diagnosis and treatment of gastric cancer.

摘要

免疫抑制受体在器官移植、自身免疫性疾病和癌症中发挥着重要作用。免疫球蛋白样转录物 (ILT)2 和 ILT3 属于 ILT 家族的抑制性受体,据报道它们可以调节广泛的与免疫反应相关的细胞功能。它们包含免疫受体酪氨酸抑制基序 (ITIM),与免疫调节有关。尽管 ILT 受体已在树突状细胞 (DCs)、T 细胞、NK 细胞和其他细胞类型中进行了研究,但 ILT2 和 ILT3 在胃癌中的表达和临床意义尚未阐明。在这里,检测了 ILT2 和 ILT3 在胃癌细胞系和病理组织中的表达,以及它们对 NK92MI 对具有 ILT2lowILT3low 的胃癌细胞系 MKNI 和具有 ILT2highILT3high 的 HGC-27 的细胞毒性的影响。结果表明,ILT2 和 ILT3 在胃癌细胞和组织中以不同程度表达,ILT2 的表达与肿瘤的分化和大小有关。此外,NK92MI 对 MKNI 细胞系的细胞毒性活性强于对 HGC-27 的细胞毒性活性。本研究表明,ILT2 和 ILT3 在胃癌免疫逃逸中发挥着关键作用,ILT2 可能成为胃癌临床诊断和治疗的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/9af804b49a9a/MMR-05-04-0910-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/ecdf173978ef/MMR-05-04-0910-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/922c159b3e9c/MMR-05-04-0910-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/bf6d7dbd4226/MMR-05-04-0910-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/9af804b49a9a/MMR-05-04-0910-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/ecdf173978ef/MMR-05-04-0910-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/922c159b3e9c/MMR-05-04-0910-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/bf6d7dbd4226/MMR-05-04-0910-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6672/3493079/9af804b49a9a/MMR-05-04-0910-g04.jpg

相似文献

1
Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance.免疫球蛋白样转录物(ILT)2 和 ILT3 在人胃癌中的表达及其临床意义。
Mol Med Rep. 2012 Apr;5(4):910-6. doi: 10.3892/mmr.2012.744. Epub 2012 Jan 9.
2
Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.人类白细胞抗原-G通过免疫球蛋白样转录物2抑制胃癌中自然杀伤细胞的抗肿瘤作用。
Cell Physiol Biochem. 2017;44(5):1828-1841. doi: 10.1159/000485819. Epub 2017 Dec 7.
3
Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation.免疫球蛋白样转录物ILT2、ILT3和ILT7由人树突状细胞表达,并在激活后下调。
Gene. 2004 Apr 28;331:159-64. doi: 10.1016/j.gene.2004.02.018.
4
Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor.免疫球蛋白样转录物2(CD85j)白细胞受体基于免疫受体酪氨酸抑制基序的突变分析。
J Immunol. 2002 Apr 1;168(7):3351-9. doi: 10.4049/jimmunol.168.7.3351.
5
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.人类抑制性受体免疫球蛋白样转录物2(ILT2)和ILT4与CD8竞争结合MHC I类分子,并优先结合HLA - G。
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8856-61. doi: 10.1073/pnas.1431057100. Epub 2003 Jul 9.
6
Transcriptional regulation of ILT family receptors.免疫球蛋白样转录物(ILT)家族受体的转录调控
J Immunol. 2003 Dec 15;171(12):6611-20. doi: 10.4049/jimmunol.171.12.6611.
7
HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.HLA I类分子通过抑制性受体ILT2/CD85j调节靶细胞、病毒产物或未成熟树突状细胞在自然杀伤细胞中诱导产生的γ干扰素。
J Immunol. 2008 Aug 15;181(4):2368-81. doi: 10.4049/jimmunol.181.4.2368.
8
HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.HLA-G可上调抗原呈递细胞、自然杀伤细胞和T细胞中的ILT2、ILT3、ILT4和KIR2DL4。
FASEB J. 2005 Apr;19(6):662-4. doi: 10.1096/fj.04-1617fje. Epub 2005 Jan 24.
9
Cyclosporine induces up-regulation of immunoglobulin-like transcripts 3 and 4 expression on and activity of NKL cells.
Transplant Proc. 2012 Jun;44(5):1407-11. doi: 10.1016/j.transproceed.2011.10.056.
10
ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.ILT3 促进非小细胞肺癌肿瘤细胞的迁移和血管生成。
Cancer Lett. 2021 Mar 31;501:263-276. doi: 10.1016/j.canlet.2020.10.048. Epub 2020 Nov 3.

引用本文的文献

1
Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications.人类疾病中的抑制性白细胞免疫球蛋白样受体B亚家族(LILRBs):结构、作用、机制及临床应用
Theranostics. 2025 Jul 25;15(16):8222-8258. doi: 10.7150/thno.116951. eCollection 2025.
2
Comprehensive analysis of the leukocyte immunoglobulin-like receptor family in clear cell renal cell carcinoma.透明细胞肾细胞癌中白细胞免疫球蛋白样受体家族的综合分析
Ann Med. 2025 Dec;57(1):2546684. doi: 10.1080/07853890.2025.2546684. Epub 2025 Aug 22.
3
The Role of LAIR1 as a Regulatory Receptor of Antitumor Immune Cell Responses and Tumor Cell Growth and Expansion.

本文引用的文献

1
IL-10 enhances promoter activity of ILT4 gene and up-regulates its expression in THP-1 cells.白细胞介素-10增强白细胞免疫球蛋白样受体4基因的启动子活性并上调其在人单核细胞白血病细胞系THP-1中的表达。
J Huazhong Univ Sci Technolog Med Sci. 2010 Oct;30(5):594-8. doi: 10.1007/s11596-010-0548-8. Epub 2010 Nov 10.
2
Gene profile analysis of CD8(+) ILT3-Fc induced T suppressor cells.CD8(+) ILT3-Fc 诱导的 T 抑制细胞的基因谱分析。
Hum Immunol. 2011 Feb;72(2):107-14. doi: 10.1016/j.humimm.2010.10.012. Epub 2010 Nov 4.
3
Surgical treatment for peritoneal carcinomatosis from gastric cancer.
LAIR1作为抗肿瘤免疫细胞反应以及肿瘤细胞生长与增殖的调节性受体的作用。
Biomolecules. 2025 Jun 13;15(6):866. doi: 10.3390/biom15060866.
4
Leukocyte immunoglobulin-like receptor B4 (LILRB4) in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target.急性髓系白血病中的白细胞免疫球蛋白样受体B4(LILRB4):从预后生物标志物到免疫治疗靶点
Chin Med J (Engl). 2024 Nov 20;137(22):2697-2711. doi: 10.1097/CM9.0000000000003195. Epub 2024 Jul 8.
5
Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients.头颈部鳞状细胞癌患者中HLA-G 14bp插入/缺失多态性及HLA-G、ILT2和ILT4表达的分析
Diseases. 2024 Feb 8;12(2):34. doi: 10.3390/diseases12020034.
6
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting.微卫星不稳定癌症中PD(L)-1阻断之外:免疫共抑制受体靶向治疗的现状
Cancers (Basel). 2024 Jan 9;16(2):281. doi: 10.3390/cancers16020281.
7
Human leukocyte immunoglobulin-like receptors in health and disease.人类白细胞免疫球蛋白样受体在健康与疾病中的作用。
Front Immunol. 2023 Nov 13;14:1282874. doi: 10.3389/fimmu.2023.1282874. eCollection 2023.
8
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.靶向 LILRB1 在癌症固有和适应性免疫检查点治疗中的研究进展。
Front Immunol. 2023 Sep 13;14:1240275. doi: 10.3389/fimmu.2023.1240275. eCollection 2023.
9
Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma.LILRB1 表达升高预示着胶质瘤患者预后不良,并与肿瘤免疫浸润有关。
BMC Cancer. 2023 May 4;23(1):403. doi: 10.1186/s12885-023-10906-2.
10
Comprehensive analysis of LILR family genes expression and tumour-infiltrating immune cells in early-stage pancreatic ductal adenocarcinoma.早期胰腺导管腺癌中 LILR 家族基因表达与肿瘤浸润免疫细胞的综合分析。
IET Syst Biol. 2023 Apr;17(2):39-57. doi: 10.1049/syb2.12058. Epub 2023 Feb 7.
胃癌腹膜转移的外科治疗。
Eur J Surg Oncol. 2010 Dec;36(12):1131-8. doi: 10.1016/j.ejso.2010.09.006. Epub 2010 Oct 8.
4
Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection.白细胞免疫球蛋白样受体对 Toll 样受体活性的调节及其在细菌感染过程中的作用。
Mediators Inflamm. 2010;2010:536478. doi: 10.1155/2010/536478. Epub 2010 Jun 20.
5
Receptors and ligands implicated in human T cell costimulatory processes.涉及人类 T 细胞共刺激过程的受体和配体。
Immunol Lett. 2010 Feb 16;128(2):89-97. doi: 10.1016/j.imlet.2009.11.009. Epub 2009 Nov 24.
6
Inhibitory receptors on myeloid cells: new targets for therapy?髓系细胞上的抑制性受体:治疗的新靶点?
Pharmacol Ther. 2010 Jan;125(1):128-37. doi: 10.1016/j.pharmthera.2009.10.007. Epub 2009 Nov 11.
7
The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection.抑制性受体 LILRB4(ILT3)调节抗原呈递细胞的表型,并且与 LILRB2(ILT4)一样,在受到沙门氏菌感染时上调。
BMC Immunol. 2009 Oct 27;10:56. doi: 10.1186/1471-2172-10-56.
8
ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.白细胞介素 2/人类白细胞抗原 G 相互作用通过抑制 NK 细胞激活突触的晚期而不是早期事件来损害 NK 细胞功能。
FASEB J. 2010 Mar;24(3):689-99. doi: 10.1096/fj.09-135194. Epub 2009 Oct 19.
9
Role of immunolglobulin-like transcript family receptors and their ligands in suppressor T-cell-induced dendritic cell tolerization.免疫球蛋白样转录家族受体及其配体在抑制性 T 细胞诱导树突状细胞耐受中的作用。
Hum Immunol. 2009 Sep;70(9):686-91. doi: 10.1016/j.humimm.2009.06.003. Epub 2009 Jun 11.
10
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.